Carbapenem-resistant enterobacteriaceae: occult threat in the intensive care unit

Area of Science:

• Infectious Diseases
• Microbiology
• Critical Care Medicine

Background:

• Carbapenem-resistant Enterobacteriaceae (CRE) are highly virulent, drug-resistant gram-negative bacteria causing increasingly common and severe infections.
• CRE infections are associated with substantial morbidity, mortality, and elevated healthcare expenses.
• Effective management necessitates early identification of at-risk patients, precise organism identification, and timely, appropriate therapeutic interventions.

Purpose of the Study:

• To highlight the growing threat of Carbapenem-resistant Enterobacteriaceae (CRE) infections.
• To emphasize the importance of prompt diagnosis and management strategies for CRE.
• To underscore the role of surveillance and infection control in preventing CRE outbreaks.

Main Methods:

• Review of current literature on Carbapenem-resistant Enterobacteriaceae (CRE) epidemiology and clinical management.
• Analysis of factors contributing to the spread of CRE in healthcare settings, particularly intensive care units.
• Emphasis on the critical role of healthcare professionals, especially critical care nurses, in infection control.

Main Results:

• Carbapenem-resistant Enterobacteriaceae (CRE) infections lead to high morbidity and mortality.
• Inadequate infection control practices, including delayed isolation and antibiotic administration (e.g., tigecycline, polymyxins), facilitate CRE spread.
• Lack of awareness regarding patient risk factors and proper protocols exacerbates the problem.

Conclusions:

• Surveillance and robust infection control measures are essential to prevent Carbapenem-resistant Enterobacteriaceae (CRE) outbreaks.
• Critical care nurses play a pivotal role in monitoring at-risk patients and implementing preventive strategies.
• Prompt recognition, diagnosis, and treatment are vital for improving outcomes in patients with CRE infections.